Lgt Financial Advisors LLC Merck & Co., Inc. Transaction History

Lgt Financial Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$113.24 - $131.95 $5,095 - $5,937	-45 Reduced 78.95%	12 $1.58 Million
Q4 2023 Feb 12, 2024	SELL	$100.18 - $109.02 $1,502 - $1,635	-15 Reduced 20.83%	57 $6.21 Million
Q3 2023 Nov 01, 2023	SELL	$102.95 - $114.33 $803,524 - $892,345	-7,805 Reduced 99.09%	72 $7.41 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $461,049 - $502,523	4,245 Added 116.88%	7,877 $909 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $373,878 - $417,171	3,632 New	3,632 $386 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Lgt Financial Advisors LLC with notifications on news.